Navigation Links
National Pharmaceutical Council Comments on Patient-Centered Outcomes Research Institute Board of Governors
Date:9/23/2010

WASHINGTON, Sept. 23 /PRNewswire-USNewswire/ -- National Pharmaceutical Council (NPC) President Dan Leonard today commented on the appointment of the Board of Governors for the Patient-Centered Outcomes Research Institute (PCORI), a private, non-profit corporation created by the health reform law to develop and fund comparative effectiveness research (CER).  

"The decisions made by this first PCORI board will have a significant impact on the future of CER and its utility for health care decision makers," said Leonard. "After all, this board, along with the methodology committee, will be setting the framework for determining CER priorities, developing sound standards and methodologies for data and research, and translating research results in a useful and understandable way."

Leonard also outlined some general principles to ensure that CER will work to provide the best health outcomes for patients.

"Given the importance of the research that will be developed, the Board must ensure that there is a broad opportunity for discussion about CER findings by all key stakeholders who generate or disseminate this information," he said. He added that CER end users—health care decision makers who include patients, payers and physicians, among others—also will benefit from the harmonization of appropriate standards for CER generation because it will enable a more predictable environment for the adoption and use of evidence in decision-making.

"NPC applauds the Comptroller General for selecting a diverse and well qualified group of individuals to serve as PCORI's first board of governors," said Leonard. "We look forward to working with the members of PCORI as they prepare for the hard work that lies ahead."

NPC supported the creation of PCORI and outlined several principles for consideration in its testimony and comments before the federal agencies involved in the development of PCORI. NPC's previous comments on CER and related research are available at www.npcnow.org. In addition, NPC has several studies currently underway looking at CER's impact on innovation and patient access, the standards for evidence generation, and at the differences in standards for generating evidence among government health agencies. These studies can help health care stakeholders better understand the current CER environment as they consider new research methods and standards.

About the National Pharmaceutical Council

NPC's overarching mission is to sponsor and conduct scientific analyses of the appropriate use of biopharmaceuticals and the clinical and economic value of innovation. The organization's strategic focus is on evidence-based medicine (EBM) for health care decision-making, to ensure that patients have access to high-quality care. NPC was established in 1953 and is supported by the nation's major NPC was established in 1953 and is supported by the nation's major research-based pharmaceutical companies. For more information, visit www.npcnow.org.


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
3. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
4. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
5. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
6. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
7. Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month
8. K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security
9. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
10. September is National Pain Awareness Month
11. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... Fla. , Feb. 20, 2017 Seal ... its health IT solution for mobile device management and ... 2017 HIMSS Conference and Exhibition in Orlando, ... #4444. Mobile devices have become commonplace in ... comes a new set of concerns, including the disinfection ...
(Date:2/20/2017)... 20, 2017 According to a new market research ... powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End ... The market is projected to reach USD 52.37 Billion by 2021 from ... forecast period. Continue Reading ... ...
(Date:2/19/2017)... 2017   AC Group Inc. , a leading ... vendors in the PMS/EHR healthcare marketplace, will exhibit the ... to succeed in this ecosystem at HIMSS,17. ... obtained from over 200 ACOs, compared and analyzed an ... companies that are providing different pieces of Population Health ...
Breaking Medicine Technology:
(Date:2/20/2017)... (PRWEB) , ... February 20, 2017 , ... ... technology, welcomes you to stop by for a visit this week at HIMSS ... clinicians and executives from around the globe. Sensogram will be featured in the ...
(Date:2/20/2017)... , ... February 20, 2017 , ... Johns Hopkins All ... education building. A topping out ceremony on Friday marked the halfway point of construction ... to open in Fall 2018, will serve as a center for innovation aimed at ...
(Date:2/19/2017)... ... February 19, 2017 , ... The Citadel’s new Swain ... is being led by Amelia Joseph, Ph.D. Joseph was engaged by the college as ... nursing department in early 2016. After a nation-wide search, she was selected to head ...
(Date:2/19/2017)... ... February 19, 2017 , ... Orbita, Inc., a ... with Healthwise ® at HIMSS 2017 to showcase a breakthrough ... health education, technology and services, will demonstrate a voice-powered knowedge assistant based on ...
(Date:2/18/2017)... Beverly Hills, California (PRWEB) , ... February 17, ... ... 273-3007, info@drvallecillos.com , drvallecillos.com , Beverly Hills plastic surgeon ... reduce subcutaneous fat cells. , Dr. Vallecillos says, "Traditionally, plastic surgery has been ...
Breaking Medicine News(10 mins):